H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Microbiology D-index 57 Citations 8,532 201 World Ranking 1399 National Ranking 589

Research.com Recognitions

Awards & Achievements

Fellow of the European Confederation of Medical Mycology (ECMM)

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Fungus
  • Antibiotics

Microbiology, Aspergillosis, Pharmacology, Mycosis and Aspergillus are his primary areas of study. His In vivo research extends to Microbiology, which is thematically connected. His biological study spans a wide range of topics, including Cancer, Amphotericin B and Gliotoxin.

The Pharmacology study which covers Caspofungin that intersects with In vitro and Calcineurin. He interconnects Aspergillus fumigatus, Intensive care medicine and Pathology in the investigation of issues within Mycosis. His work in Aspergillus addresses issues such as Azole, which are connected to fields such as Zygomycosis, Minimum inhibitory concentration and Mucormycosis.

His most cited work include:

  • Pharmacodynamics of Caspofungin in a Murine Model of Invasive Pulmonary Aspergillosis: Evidence of Concentration-Dependent Activity (185 citations)
  • Pharmacodynamics of Caspofungin in a Murine Model of Invasive Pulmonary Aspergillosis: Evidence of Concentration-Dependent Activity (185 citations)
  • Pharmacodynamics of Polymyxin B against Pseudomonas aeruginosa (159 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Microbiology, Pharmacology, Fluconazole, Voriconazole and Caspofungin. Antifungal is closely connected to In vitro in his research, which is encompassed under the umbrella topic of Microbiology. His research in Pharmacology intersects with topics in Potency and In vivo.

He works mostly in the field of Fluconazole, limiting it down to concerns involving Cryptococcus neoformans and, occasionally, Cryptococcosis. His work deals with themes such as Itraconazole, Aspergillosis and Lung, which intersect with Voriconazole. His Aspergillosis study incorporates themes from Aspergillus fumigatus, Mycosis and Aspergillus.

He most often published in these fields:

  • Microbiology (58.61%)
  • Pharmacology (27.48%)
  • Fluconazole (18.54%)

What were the highlights of his more recent work (between 2017-2021)?

  • Microbiology (58.61%)
  • Fluconazole (18.54%)
  • Posaconazole (11.26%)

In recent papers he was focusing on the following fields of study:

Nathan P. Wiederhold mainly investigates Microbiology, Fluconazole, Posaconazole, In vivo and Voriconazole. His research on Microbiology frequently connects to adjacent areas such as Fusarium. His Fluconazole research is multidisciplinary, incorporating perspectives in Coccidioides immitis, Azole, Candida auris and Candida albicans.

His Azole research integrates issues from Aspergillus fumigatus and Aspergillosis. His work in In vivo covers topics such as Pharmacology which are related to areas like Kidney. His Voriconazole research includes elements of Itraconazole, Terbinafine and Myeloid leukemia.

Between 2017 and 2021, his most popular works were:

  • Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. (121 citations)
  • Coelomycetous Dothideomycetes with emphasis on the families Cucurbitariaceae and Didymellaceae. (52 citations)
  • Fungal infections in animals: A patchwork of different situations (41 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Fungus
  • Gene

The scientist’s investigation covers issues in Microbiology, Caspofungin, In vivo, Fluconazole and Posaconazole. Many of his studies on Microbiology involve topics that are commonly interrelated, such as Aspergillosis. His Caspofungin research is multidisciplinary, relying on both Intraperitoneal injection, Candida glabrata, Echinocandin and Kidney.

His research integrates issues of Inoculation, In vitro, Central nervous system, Coccidioides immitis and Pharmacology in his study of In vivo. The various areas that Nathan P. Wiederhold examines in his Fluconazole study include Candida auris and Candida albicans. His Posaconazole research incorporates elements of Aspergillus, Amphotericin B deoxycholate, Guideline, Disease management and Rare disease.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Pharmacodynamics of Caspofungin in a Murine Model of Invasive Pulmonary Aspergillosis: Evidence of Concentration-Dependent Activity

Nathan P. Wiederhold;Nathan P. Wiederhold;Dimitrios P. Kontoyiannis;Dimitrios P. Kontoyiannis;Jingduan Chi;Randall A. Prince;Randall A. Prince.
The Journal of Infectious Diseases (2004)

232 Citations

Antifungal resistance: current trends and future strategies to combat.

Nathan P Wiederhold.
Infection and Drug Resistance (2017)

212 Citations

Pharmacodynamics of Polymyxin B against Pseudomonas aeruginosa

Vincent H. Tam;Amy N. Schilling;Giao Vo;Samer Kabbara.
Antimicrobial Agents and Chemotherapy (2005)

212 Citations

Detection of Gliotoxin in Experimental and Human Aspergillosis

Russell E. Lewis;Russell E. Lewis;Nathan P. Wiederhold;Nathan P. Wiederhold;Jingduan Chi;Xiang-Yang Han.
Infection and Immunity (2005)

193 Citations

The echinocandin antifungals: an overview of the pharmacology, spectrum and clinical efficacy.

Nathan P Wiederhold;Russell E Lewis.
Expert Opinion on Investigational Drugs (2003)

184 Citations

Fungal Planet description sheets: 320–370

P. W. Crous;M. J. Wingfield;J. Guarro;M. Hernández-Restrepo.
Persoonia (2015)

177 Citations

Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium.

Oliver A. Cornely;Ana Alastruey-Izquierdo;Dorothee Arenz;Sharon C. A. Chen.
Lancet Infectious Diseases (2019)

175 Citations

Fungal Planet description sheets: 400–468

P. W. Crous;P. W. Crous;M. J. Wingfield;D. M. Richardson;J. J. Le Roux.
Persoonia (2016)

168 Citations

Development of Caspofungin Resistance following Prolonged Therapy for Invasive Candidiasis Secondary to Candida glabrata Infection

George Richard Thompson;Nathan P. Wiederhold;Nathan P. Wiederhold;Ana C. Vallor;Nyria C. Villareal.
Antimicrobial Agents and Chemotherapy (2008)

164 Citations

Attenuation of the Activity of Caspofungin at High Concentrations against Candida albicans: Possible Role of Cell Wall Integrity and Calcineurin Pathways

Nathan P. Wiederhold;Dimitrios P. Kontoyiannis;Dimitrios P. Kontoyiannis;Randall A. Prince;Randall A. Prince;Russell E. Lewis;Russell E. Lewis.
Antimicrobial Agents and Chemotherapy (2005)

163 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Nathan P. Wiederhold

Dimitrios P. Kontoyiannis

Dimitrios P. Kontoyiannis

The University of Texas MD Anderson Cancer Center

Publications: 89

Russell E. Lewis

Russell E. Lewis

University of Bologna

Publications: 87

Kevin D. Hyde

Kevin D. Hyde

Mae Fah Luang University

Publications: 87

Pedro W. Crous

Pedro W. Crous

Utrecht University

Publications: 79

Jacques F. Meis

Jacques F. Meis

Canisius-Wilhelmina Ziekenhuis

Publications: 76

Thomas J. Walsh

Thomas J. Walsh

Weill Cornell Medicine

Publications: 68

Maiken Cavling Arendrup

Maiken Cavling Arendrup

Statens Serum Institut

Publications: 59

Paul E. Verweij

Paul E. Verweij

Radboud University Nijmegen

Publications: 58

Josep Guarro

Josep Guarro

Rovira i Virgili University

Publications: 56

David S. Perlin

David S. Perlin

Rutgers, The State University of New Jersey

Publications: 56

Oliver A. Cornely

Oliver A. Cornely

University of Cologne

Publications: 50

David R. Andes

David R. Andes

University of Wisconsin–Madison

Publications: 46

Sharon C.-A. Chen

Sharon C.-A. Chen

University of Sydney

Publications: 41

Shawn R. Lockhart

Shawn R. Lockhart

Centers for Disease Control and Prevention

Publications: 35

John R. Perfect

John R. Perfect

Duke University

Publications: 35

Teun Boekhout

Teun Boekhout

University of Amsterdam

Publications: 35

Something went wrong. Please try again later.